BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15677349)

  • 1. Selective inhibition of dog hepatic CYP2B11 and CYP3A12.
    Lu P; Singh SB; Carr BA; Fang Y; Xiang CD; Rushmore TH; Rodrigues AD; Shou M
    J Pharmacol Exp Ther; 2005 May; 313(2):518-28. PubMed ID: 15677349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450.
    Shou M; Norcross R; Sandig G; Lu P; Li Y; Lin Y; Mei Q; Rodrigues AD; Rushmore TH
    Drug Metab Dispos; 2003 Sep; 31(9):1161-9. PubMed ID: 12920172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the effects of tebufelone on hepatic cytochromes P450 in the beagle dog.
    Smith BJ; Zupan LA; Hu JK; Diters RW; Gibson GW; Norton JN
    Drug Metab Dispos; 1996 May; 24(5):523-8. PubMed ID: 8723731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cytochrome P450 (CYP3A12) induction by rifampicin in dog liver.
    Nishibe Y; Wakabayashi M; Harauchi T; Ohno K
    Xenobiotica; 1998 Jun; 28(6):549-57. PubMed ID: 9667078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases.
    Jung F; Richardson TH; Raucy JL; Johnson EF
    Drug Metab Dispos; 1997 Feb; 25(2):133-9. PubMed ID: 9029042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of bergamottin on diazepam plasma levels and P450 enzymes in beagle dogs.
    Sahi J; Reyner EL; Bauman JN; Gueneva-Boucheva K; Burleigh JE; Thomas VH
    Drug Metab Dispos; 2002 Feb; 30(2):135-40. PubMed ID: 11792681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences.
    Hay Kraus BL; Greenblatt DJ; Venkatakrishnan K; Court MH
    Xenobiotica; 2000 Jun; 30(6):575-88. PubMed ID: 10923860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
    Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
    Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity and kinetics of inactivation of rabbit hepatic cytochromes P450 2B4 and 2B5 by N-aralkylated derivatives of 1-aminobenzotriazole.
    Grimm SW; Bend JR; Halpert JR
    Drug Metab Dispos; 1995 May; 23(5):577-83. PubMed ID: 7587934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-based inactivation of CYP2C11 by diclofenac.
    Masubuchi Y; Ose A; Horie T
    Drug Metab Dispos; 2001 Sep; 29(9):1190-5. PubMed ID: 11502726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
    John GH; Hasler JA; He YA; Halpert JR
    Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates.
    Graham MJ; Bell AR; Crewe HK; Moorcraft CL; Walker L; Whittaker EF; Lennard MS
    Xenobiotica; 2003 Mar; 33(3):225-37. PubMed ID: 12637241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of canine cytochrome P-450s (CYPs) metabolizing the tramadol (+)-M1 and (+)-M2 metabolites to the tramadol (+)-M5 metabolite in dog liver microsomes.
    Perez Jimenez TE; Mealey KL; Schnider D; Grubb TL; Greene SA; Court MH
    J Vet Pharmacol Ther; 2018 Dec; 41(6):815-824. PubMed ID: 30113702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaction phenotyping of vinblastine metabolism in dogs.
    Achanta S; Maxwell LK
    Vet Comp Oncol; 2016 Jun; 14(2):161-9. PubMed ID: 24502418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    BourriƩ M; Meunier V; Berger Y; Fabre G
    J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
    Butler AM; Murray M
    Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine CYP2B11 metabolizes and is inhibited by anesthetic agents often co-administered in dogs.
    Baratta MT; Zaya MJ; White JA; Locuson CW
    J Vet Pharmacol Ther; 2010 Feb; 33(1):50-5. PubMed ID: 20444025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.